Free Trial
NASDAQ:OXBR

Oxbridge Re Q3 2025 Earnings Report

Oxbridge Re logo
$1.71 -0.08 (-4.47%)
Closing price 10/17/2025 03:59 PM Eastern
Extended Trading
$1.72 +0.02 (+0.88%)
As of 10/17/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Oxbridge Re EPS Results

Actual EPS
N/A
Consensus EPS
-$0.01
Beat/Miss
N/A
One Year Ago EPS
N/A

Oxbridge Re Revenue Results

Actual Revenue
N/A
Expected Revenue
$0.74 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Oxbridge Re Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Wednesday, November 12, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Oxbridge Re Earnings Headlines

E-learning students left 'high and dry'
Nvidia CEO Makes First Ever Tesla Announcement
While headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $25 trillion AI revolution — one that Nvidia’s CEO himself has called a “multi-trillion-dollar future industry” — and he’s uncovered a little-known stock 168 times smaller than Nvidia that could be positioned to ride this breakthrough.tc pixel
Oxbridge / SurancePlus to Attend TOKEN2049 Singapore
See More Oxbridge Re Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Oxbridge Re? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Oxbridge Re and other key companies, straight to your email.

About Oxbridge Re

Oxbridge Re (NASDAQ:OXBR) (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents. Oxbridge Re works closely with insurers to structure agreements that align risk retention levels, collateral requirements, and profit-sharing mechanics. These arrangements often feature customized features such as experience refunds, corridor enhancements, and risk corridors, providing clients with flexibility in managing long-term liabilities.

Oxbridge Re serves a diversified client base across North America, focusing primarily on life, annuity, and disability insurance portfolios. Its underwriting team brings experience in actuarial modeling, financial analysis, and regulatory compliance, supporting transactions that span single-life, group life, living benefits, and specialized guarantee products. While relatively new to the public markets, Oxbridge Re has built strategic alliances with financial institutions and reinsurers to broaden its capital resources and co‐reinsurance capabilities.

Governed by a board with backgrounds in insurance operations, capital markets, and risk management, Oxbridge Re emphasizes disciplined underwriting standards and capital-efficient structuring. The company aims to differentiate itself through innovative deal design and responsive client service, positioning its platform to address evolving regulatory requirements and competitive pressures within the reinsurance industry.

View Oxbridge Re Profile

More Earnings Resources from MarketBeat